Smith & Nephew (Smith & Nephew) Debt-to-Equity

: 0.59 (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

Smith & Nephew's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $765 Mil. Smith & Nephew's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2,319 Mil. Smith & Nephew's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $5,217 Mil. Smith & Nephew's debt to equity for the quarter that ended in Dec. 2023 was 0.59.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Smith & Nephew's Debt-to-Equity or its related term are showing as below:

SNN' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.3 Med: 0.42 Max: 0.7
Current: 0.59

During the past 13 years, the highest Debt-to-Equity Ratio of Smith & Nephew was 0.70. The lowest was 0.30. And the median was 0.42.

SNN's Debt-to-Equity is ranked worse than
77.14% of 713 companies
in the Medical Devices & Instruments industry
Industry Median: 0.21 vs SNN: 0.59

Smith & Nephew Debt-to-Equity Historical Data

The historical data trend for Smith & Nephew's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Smith & Nephew Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.40

0.70

0.60

0.55

0.59

Smith & Nephew Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.60	0.54	0.55	0.58	0.59

Competitive Comparison

For the Medical Devices subindustry, Smith & Nephew's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smith & Nephew Debt-to-Equity Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Smith & Nephew's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Smith & Nephew's Debt-to-Equity falls into.

Smith & Nephew Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Smith & Nephew's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(765	+	2319)	/	5217
	=	0.59

Smith & Nephew's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(765	+	2319)	/	5217
	=	0.59

Smith & Nephew (NYSE:SNN) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Smith & Nephew Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Smith & Nephew's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Smith & Nephew (Smith & Nephew) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Smith & Nephew PLC (NYSE:SNN) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

SNNUF:USA SNl:UK SN.:UK NPW1:Germany NPWA:Germany NPW1:Germany S1NN34:Brazil

Address

Hatters Lane, Building 5, Croxley Park, Watford, Hertfordshire, GBR, WD18 8YE

Website

https://www.smith-nephew.com

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 41% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.